Back to top

Strength Seen in Lannett Company (LCI): Stock Gains 8.7%
December 03, 2013

Read MoreHide Full Article
Lannett Company, Inc. (LCI - Free Report) was a big mover last session, as the company saw its shares rise by nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up almost 35% since Nov 7.

This manufacturer and marketer of generic versions of branded pharmaceutical products has seen 3 positive revisions in the past one month. Also, the Zacks Consensus Estimate has moved higher over the same time frame, suggesting that more solid trading could be ahead for Lannett. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Lannett currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Investors interested in the med-drugs industry may also consider stocks like Jazz Pharmaceuticals Public Limited Company (JAZZ - Free Report) , Questcor Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, Inc. (SCMP - Free Report) . All these stocks carry the same Zacks Rank as Lannett.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lannett Co Inc (LCI) - free report >>

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

Sucampo Pharmaceuticals, Inc. (SCMP) - free report >>

More from Zacks Tale of the Tape

You May Like